Cellcom Israel Ltd.

As of March 31, 2026, Cellcom Israel Ltd. carries a market capitalization of 569.85B, placing it among publicly traded companies globally. Its enterprise value stands at 732.35B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Cellcom Israel Ltd.'s next confirmed earnings release is scheduled for November 18, 2026.

As of March 31, 2026, Cellcom Israel Ltd. has 168.10M shares outstanding.

As of March 31, 2026, Cellcom Israel Ltd. trades at a trailing price-to-earnings ratio of 9.90. The price-to-sales ratio is 1.38, and the price-to-book ratio stands at 2.10.

As of March 31, 2026, Cellcom Israel Ltd. trades at an EV/EBITDA multiple of 5.29 - the valuation measure that neutralizes differences in capital structure, tax rates, and depreciation policy, making it the standard yardstick for comparing companies across an industry. The EV/Sales ratio of 1.77 reflects the premium investors pay for the company's revenue stream, a useful check when earnings are depressed or negative. Its EV/EBIT multiple of 16.76 values the business against core operating earnings after depreciation, a stricter test than EV/EBITDA for capital-intensive businesses. Cellcom Israel Ltd. trades at an EV/FCF ratio of 10.64, comparing the total takeover cost of the business to the cash it actually generates for all capital providers. These enterprise value multiples are built on an enterprise value of 732.35B versus a market cap of 569.85B, with the gap driven by net debt and cash on the balance sheet.

As of March 31, 2026, Cellcom Israel Ltd. maintains a current ratio of 0.66, meaning it holds 0.7x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 70.95, indicating elevated leverage, while an interest coverage ratio of 13.19 demonstrates strong ability to service its debt obligations.

Over the twelve months ended March 31, 2026, Cellcom Israel Ltd. posted a return on equity (ROE) of 22.03, showing how much profit the company earns on every dollar of shareholder capital. Return on invested capital (ROIC) comes in at 7.14 - the clearest signal of whether the business earns more on its capital than that capital costs, and the core measure of a durable competitive advantage. Return on assets (ROA) stands at 9.20, measuring how efficiently the asset base is converted into earnings. Return on capital employed (ROCE) is 13.73, useful for judging operating efficiency across full business cycles. The company generates approximately 165.01M in revenue per employee across its workforce of 2,512.00, a quick read on workforce productivity versus industry peers. Inventory turnover of 22.63 indicates how many times Cellcom Israel Ltd. sells and replaces its inventory over a year, a key working capital efficiency ratio.

Over the twelve months ended March 31, 2026, Cellcom Israel Ltd. recorded 15.10B in income tax expense. That works out to an effective tax rate of 20.77, which can sit above or below the statutory corporate tax rate depending on foreign earnings mix, tax credits, and one-off items. Taxes are levied on pretax income of 72.70B, leaving 57.60B in net income after tax - the gap is what shifts in the tax rate do to reported earnings and EPS.

As of the close on October 22, 2026, Cellcom Israel Ltd.'s stock has gained approximately 1.53% over the past 52 weeks. The 50-day moving average sits at 3,483.24, while the 200-day moving average is 3,544.05.

Over the twelve months ended March 31, 2026, Cellcom Israel Ltd. generated 414.50B in revenue and converted that into 57.60B in net income, yielding earnings per share of 338.54. EBITDA reached 138.50B, while operating income came in at 38.90B.

As of March 31, 2026, Cellcom Israel Ltd. holds 30.00B in cash and equivalents against 192.50B in total debt, resulting in a net debt position of 100.70B. Total book value stands at 271.30B, with working capital of -74.50B providing operational flexibility.

Cellcom Israel Ltd. produced 123.80B in operating cash flow over the twelve months ended March 31, 2026. After subtracting -63.30B in capital expenditures, free cash flow totaled 60.50B - equivalent to 359.70 per share.

Over the twelve months ended March 31, 2026, Cellcom Israel Ltd. posted a gross margin of 35.59, reflecting its pricing power and cost economics. The operating margin of 9.38 and net profit margin of 13.90 provide insight into operational efficiency.

These figures cover the twelve months ended March 31, 2026. Free cash flow yield stands at 10.49, showing how much cash the business generates relative to its market value - dividends covered by free cash flow are generally more durable than those funded by debt. Total shareholder yield reaches 18.37, combining dividends paid with share buybacks and debt reduction for a fuller picture of capital returned to Cellcom Israel Ltd. shareholders.

As of March 31, 2026, Cellcom Israel Ltd. has an Altman Z-Score of 2.73, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.